Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.150
+0.060 (2.87%)
Jun 17, 2026, 4:00 PM EDT - Market closed
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $5.91 million as of June 18, 2026. Its market cap has increased by 73.91% in one year.
Market Cap
5.91M
Enterprise Value
4.22M
1-Year Change
73.91%
Ranking
Category
Stock Price
$2.15
Market Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $5.91M, a decrease of -82.81%. That is a compound annual growth rate of -26.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 5.91M | -9.03% |
| Dec 31, 2025 | 6.50M | 124.14% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
| Oct 2, 2020 | 34.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Soligenix | 6.31M |
| Evogene | 5.98M |
| Cardio Diagnostics Holdings | 5.80M |
| BioAtla | 5.72M |
| XTL Biopharmaceuticals | 5.52M |
| Adial Pharmaceuticals | 5.44M |
| Pulmatrix | 5.44M |
| Alaunos Therapeutics | 5.43M |